
Megs Pharmaceutical Limited
Pharmaceutical trading company based in Rajasthan, established in 2017.
Pharmaceutical trading company based in Rajasthan, established in 2017.
Megs Pharmaceutical Limited (MPL) is a Public Limited Indian Non-Government Company incorporated in India on 03 August 2017 (Seven years and nine months 7 days old ). Its registered office is in Jaipur, Rajasthan, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.30 M and a paid-up capital of Rs 0.30 M.
The company currently has active open charges totaling ₹3.80 M.
Ray Singh, Vrishdev Singh, and Vijendra Rathore serve as directors at the Company.
Jaipur, Rajasthan, India
+91-XXXXXXXXXX
U74999RJ2017PLC058722
058722
Public Limited Indian Non-Government Company
03 Aug 2017
30 Sep 2023
31 Mar 2023
Unlisted
Roc Jaipur
Megs Pharmaceutical Limited offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs, Health Care Service, Gynecology Consultants, Medical Surgery & Treatment Centres, Medical Treatment Services, Pediatric Care Facilities, Common Disease Medicines, Pharmaceutical Tablets, Ayurvedic,Herbal Products & Medicine.
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ray Singh ![]() | Director | 03-Aug-2017 | Current |
Vrishdev Singh ![]() | Whole-Time Director | 03-Aug-2017 | Current |
Vijendra Rathore ![]() | Director | 26-Jan-2020 | Current |
Megs Pharmaceutical Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 46.43% increase. The company also saw a substantial improvement in profitability, with a 51.14% increase in profit. The company's net worth moved up by a moderate rise of 9.51%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
Unlock access to Megs Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Vrishdev Singh is a mutual person
₹3.80 M
₹0
Date | Lender | Amount | Status |
---|---|---|---|
16 Dec 2023 | Others | ₹2.50 M | Open |
31 Jan 2022 | Others | ₹0.20 M | Open |
01 Sep 2021 | Others | ₹1.00 M | Open |
01 Sep 2021 | Others | ₹0.10 M | Open |
Unlock and access historical data on people associated with Megs Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Megs Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Megs Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others amounted to Rs. 2.50 M with Charge ID 100889910 was registered on 16 Dec 2023.
Megs Pharmaceutical Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Megs Pharmaceutical Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Jaipur.
A charge with Others amounted to Rs. 0.20 M with Charge ID 100538203 was registered on 31 Jan 2022.
A charge with Others amounted to Rs. 1.00 M with Charge ID 100476310 was registered on 01 Sep 2021.
A charge with Others amounted to Rs. 0.10 M with Charge ID 100479818 was registered on 01 Sep 2021.
Megs Pharmaceutical Limited was incorporated on 03 Aug 2017.
The authorized share capital of Megs Pharmaceutical Limited is ₹ 0.30 M and paid-up capital is ₹ 0.30 M.
Currently 3 directors are associated with Megs Pharmaceutical Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Megs Pharmaceutical Limited is P.No.D-82 Flat No.S-1 2Nd Floor Manglam City, Vill-Hathoj India, Jaipur, Rajasthan, 302012.
The corporate identification number (CIN) of Megs Pharmaceutical Limited is U74999RJ2017PLC058722 and the company number is 058722 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2022, the revenue trend for Megs Pharmaceutical Limited has risen by 46.43%.
The financial reports for the fiscal year 2022 indicates that The net worth of Megs Pharmaceutical Limited has experienced an upsurge of 9.51%.
As per the financial statements for fiscal Year 2022, The total open charges for Megs Pharmaceutical Limited amount to ₹ 3.80 M.
The most recent Balance Sheet for Megs Pharmaceutical Limited was filed with the ROC on 31 Mar 2023.
Search company & director profiles for free and gain access to critical business data.
SS
PS